Mon, April 15, 2024

Matthew Sykes Maintained (VCYT) at Strong Buy with Decreased Target to $28 on, Apr 15th, 2024

Matthew Sykes of Goldman Sachs, Maintained "Veracyte, Inc." (VCYT) at Strong Buy with Decreased Target from $32 to $28 on, Apr 15th, 2024.

Matthew has made no other calls on VCYT in the last 4 months.



There are 2 other peers that have a rating on VCYT. Out of the 2 peers that are also analyzing VCYT, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Matthew


  • Tejas Savant of "Morgan Stanley" Maintained at Sell with Decreased Target to $21 on, Monday, February 26th, 2024
  • Mike Matson of "Needham" Maintained at Strong Buy with Increased Target to $33 on, Friday, February 23rd, 2024